{"i":{"4tRNZ_LwF":{"id":"4tRNZ_LwF","type":"slide","setup":{"bord":{"size":0,"rad":0},"bg":{"selectedKey":"fill","fill":{"opac":1,"rgb":"#fff"},"img":{"filt":{"opac":100,"gray":0,"blur":0,"tint":{"rgb":"#000000","opac":0.8}},"pos":{"type":"crop","fit":{"bg":{"color":{"rgb":"#FFF","opac":100}},"vali":"center","hali":"center"},"crop":{"poi":{"x":552,"y":360}}},"measures":{"size":{"width":1080,"height":720}}}},"transparentBg":{"selectedKey":false}}},"MpLbHB09QZ":{"id":"MpLbHB09QZ","type":"interactive","subtype":"interactiveRichText","setup":{"frmeTp":{"selectedKey":"noneFrame"},"bg":{"fill":{"opac":0.2,"rgb":"#FFF"}},"txt":{"val":{"ops":[{"insert":"Bibliografia","attributes":{"color":"#1d1d1d","bold":true}},{"insert":"\n","attributes":{"size":"medium"}},{"insert":"\n"},{"insert":"ANTHENELLI, RM., BENOWITZ, NL., WEST, R., ST AUBIN, L., MCRAE, T., LAWRENCE, D., ET AL. (2016). \"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial\". ","attributes":{"color":"var(--TC2)"}},{"insert":"The Lancet","attributes":{"italic":true,"color":"var(--TC2)"}},{"insert":"; 387(10037), 2507-2520. ","attributes":{"color":"var(--TC2)"}},{"insert":"\n","attributes":{"align":"justify","list":"bullet"}},{"insert":"APOLLONIO, D., PHILIPPS, R., BERO, L. (2016). \"Interventions for tobacco use cessation in people in treatment for or recovery from substance abuse\". ","attributes":{"color":"var(--TC2)"}},{"insert":"The Cochrane Library","attributes":{"italic":true,"color":"var(--TC2)"}},{"insert":", 12(11), 1-10.","attributes":{"color":"var(--TC2)"}},{"insert":"\n","attributes":{"align":"justify","list":"bullet"}},{"insert":"AYERS, C. R., HEFFNER, JL., RUSS, C., LAWRENCE, D., MCRAE, T., EVINS, AE., ANTHENELLI, RM. (2020). \"Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active‐ and placebo‐controlled EAGLES trial\". ","attributes":{"color":"var(--TC2)"}},{"insert":"Depression and Anxiety","attributes":{"italic":true,"color":"var(--TC2)"}},{"insert":", 37(3), 247–260. ","attributes":{"color":"var(--TC2)"}},{"insert":"\n","attributes":{"align":"justify","list":"bullet"}},{"insert":"BIDWELL, LC., KAROLY, HC., HUTCHISON, KE., BRYAN, AD. (2017). \"ADHD symptoms impact smoking outcomes and withdrawal in response to Varenicline treatment for smoking cessation\". ","attributes":{"color":"var(--TC2)"}},{"insert":"Drug and Alcohol Dependence","attributes":{"italic":true,"color":"var(--TC2)"}},{"insert":", 179, 18–24.","attributes":{"color":"var(--TC2)"}},{"insert":"\n","attributes":{"align":"justify","list":"bullet"}},{"insert":"BOLAND, VC., STOCKINGS, EA., MATTICK, RP., MCROBBIE, H., BROWN, J., COURTNEY, RJ. (2018). \"The methodological quality and effectiveness of technology-based smoking cessation interventions for disadvantaged groups: A systematic review and meta-analysis\". ","attributes":{"color":"var(--TC2)"}},{"insert":"Nicotine & Tobacco Research","attributes":{"italic":true,"color":"var(--TC2)"}},{"insert":", 20(3), 276–285.","attributes":{"color":"var(--TC2)"}},{"insert":"\n","attributes":{"align":"justify","list":"bullet"}}]},"rType":"richtext"},"vali":"top","paddV1":10,"hali":""}},"nLJQ_wesO0":{"id":"nLJQ_wesO0","type":"interactive","subtype":"interactiveImage","setup":{"img":{"filt":{"opac":100,"gray":0,"blur":0,"tint":{"rgb":"#FFF","opac":0}},"pos":{"type":"fit","fit":{"bg":{"color":{"rgb":"#c0c5cb","opac":100}},"vali":"center","hali":"center"},"crop":{"poi":{"x":118.5,"y":127.5}},"mask":{"shape":1}},"measures":{"size":{"width":255,"height":255}},"orig":{"rType":"asset","rSubType":"image","fileName":"iconoBLANCObiblio.png","fileSize":4237,"aid":"a7R4M4lML9","val":"mc-af02a004358a8f0cb7485da7318f00ba.png"}}}}},"v":"1"}